However, our MIF data suggest that the COVID-19 patients with a decline of serum MIF within 3 days after ICU admission (Responder) might belong to the low-inflammatory phenotype, while critically ill patients with an MIF increase (Non-Responder) might be assigned to a hyper-inflammatory phenotype, which is associated with a high mortality. Here, MIF is linked to COVID-19.